ENTA R&D to Revenue
Enanta Pharmaceuticals Inc · R&D to Revenue
ENTA R&D to Revenue
Latest reported163.40%period ending
ENTA FY R&D/Revenue (42.68% → 163.40%)
Latest values, visible window
High-resolution chart · PNG
ENTA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 163.4009% | |
| 194.3905% | |
| 206.4593% | |
| 190.9494% | |
| 179.359% | |
| 111.6622% | |
| 69.3056% | |
| 45.9073% | |
| 55.8786% | |
| 45.8388% | |
| 14.4138% | |
| 39.2535% | |
| 52.5411% | |
| 36.2418% | |
| 27.5703% | |
| 42.6833% |